ITGR
NYSEInteger Holdings Corporation
SectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
Price$126.72+0.01 (+0.01%)
01:45 PM07:45 PM
News · 26 weeks56+50%
2026-04-192026-10-11
Mix2690d
- SEC Filings18(69%)
- Other4(15%)
- Insider3(12%)
- Earnings1(4%)
Latest news
25 items- INSIDERSEC Form 3 filed by Integer Holdings Corporation3 - Integer Holdings Corp (0001114483) (Issuer)
- SECSEC Form 8-K filed by Integer Holdings Corporation8-K - Integer Holdings Corp (0001114483) (Filer)
- SECInteger Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Integer Holdings Corp (0001114483) (Filer)
- PRInteger Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) ("Integer" or the "Company"), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the "Notes") that the Notes are convertible, at the option of the holders (the "Conversion Option") beginning on October 1, 2026, and ending at the close of business on December 31, 2026. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company’s common stock or a combination thereof, at the Company’s election, in respect of the remainder, if any, of the Company’s conver
- SECInteger Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Integer Holdings Corp (0001114483) (Filer)
- PRInteger Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKRPLANO, Texas, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) ("Integer" or the "Company"), a leading global medical device contract development and manufacturing organization (CDMO), today announced that it has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with the previously announced acquisition of Integer by an affiliate of investment funds managed by KKR (the "Merger"). As previously announced on August 3, 2026, Integer and KKR entered into a definitive merger agreement dated as of August 2, 2026 (the "Merger Agreement") pursuant to which an affiliate of KK
- INSIDERChief Human Resources Officer Thor Kirk K sold $3,981,726 worth of shares (31,540 units at $126.24), decreasing direct ownership by 82% to 7,153 units (SEC Form 4)4 - Integer Holdings Corp (0001114483) (Issuer)
- SECSEC Form DEFM14A filed by Integer Holdings CorporationDEFM14A - Integer Holdings Corp (0001114483) (Filer)
- INSIDERPresident, Growth & Innovation Senn Andrew sold $1,188,230 worth of shares (9,408 units at $126.30), decreasing direct ownership by 64% to 5,405 units (SEC Form 4)4 - Integer Holdings Corp (0001114483) (Issuer)
- SECSEC Form PREM14A filed by Integer Holdings CorporationPREM14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- PRINTEGER HOLDINGS: Kaskela Law Announces Probe into Adequacy of $127.00 Per Share Buyout Price – Fair or Inadequately Low for the Company’s Shareholders?Kaskela Law is currently investigating the adequacy of the Integer Holdings Corporation (NYSE:ITGR) ("Integer" or the "Company") shareholder buyout proposal to determine whether the Company’s investors may be able to obtain a higher price for their shares. Click here for additional information: https://kaskelalaw.com/case/integer-holdings/ On August 3, 2026, Integer announced that it had agreed to be acquired by funds affiliated with private equity firm KKR & Co. ("KKR") at a price of $127.00 per share in cash. Following the closing of the proposed transaction, Integer shareholders will be cashed out of their investment position and the Company’s shares will no longer be publicly traded
- SECSEC Form 10-Q filed by Integer Holdings Corporation10-Q - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECInteger Holdings Corporation filed SEC Form 8-K: Financial Statements and Exhibits8-K - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECSEC Form DEFA14A filed by Integer Holdings CorporationDEFA14A - Integer Holdings Corp (0001114483) (Filer)
- SECInteger Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Integer Holdings Corp (0001114483) (Filer)
- SECInteger Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Integer Holdings Corp (0001114483) (Filer)
ITGR FAQ
6 questionsWhat does Integer Holdings Corporation do?
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators...Where does ITGR stock trade?
Integer Holdings Corporation (ITGR) is listed on NYSE.What sector and industry is ITGR in?
Integer Holdings Corporation operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.What are analysts saying about ITGR?
Integer Holdings Corporation has had 8 recent analyst actions on file. The most recent action was from Oppenheimer: Outperform on 2026-05-13.What companies are similar to ITGR?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), SLNO (Soleno Therapeutics Inc.). Compare ITGR side-by-side with any of them on Quantisnow.How can I track ITGR on Quantisnow?
Quantisnow aggregates Integer Holdings Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ITGR to receive live email and push alerts on every new disclosure.